Bevacizumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00112 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | desmoplastic small round cell tumor | TxGNN Knowledge Graph |
| 2 | breast neoplasm | TxGNN Knowledge Graph |
| 3 | glioblastoma (disease) | TxGNN Knowledge Graph |
| 4 | glioma susceptibility | TxGNN Knowledge Graph |
| 5 | primary peritoneal serous/papillary carcinoma | TxGNN Knowledge Graph |
| 6 | primary peritoneal carcinoma (disease) | TxGNN Knowledge Graph |
| 7 | fallopian tube cancer | TxGNN Knowledge Graph |
| 8 | peritoneum cancer | TxGNN Knowledge Graph |
| 9 | fallopian tube carcinoma | TxGNN Knowledge Graph |
| 10 | hereditary breast ovarian cancer syndrome | TxGNN Knowledge Graph |
| 11 | metastatic malignant neoplasm in the colon | TxGNN Knowledge Graph |
| 12 | squamous cell carcinoma of the corpus uteri | TxGNN Knowledge Graph |
| 13 | breast cancer | TxGNN Knowledge Graph |
| 14 | hereditary breast carcinoma | TxGNN Knowledge Graph |
| 15 | cervical carcinoma | TxGNN Knowledge Graph |
| 16 | primary malignant peritoneal tumor | TxGNN Knowledge Graph |
| 17 | malignant epithelial tumor of ovary | TxGNN Knowledge Graph |
| 18 | undifferentiated carcinoma of the corpus uteri | TxGNN Knowledge Graph |
| 19 | cervical adenocarcinoma | TxGNN Knowledge Graph |
| 20 | cervical cancer | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.